In vivo and in vitro assessment of brain bioenergetics in aging rats

Journal of Cellular and Molecular Medicine

Volumn 14, Issue 11, 2010, Pages 2667-2674

  Vančová, Ol'ga ^a   Bačiak, Ladislav ^b   Kašparová, Svatava ^b   Kucharská, Jarmila ^a   Palacios, Hector H ^c   Horeckỳ, Jaromír ^d   Aliev, Gjumrakch ^c,e,f  

^a Faculty of Medicine of Comenius University and University Hospital Bratislava   (Slovakia)

^b SLOVAK UNIVERSITY OF TECHNOLOGY   (Slovakia)

^c University of San Antonio   (United States)

^d SLOVAK MEDICAL UNIVERSITY   (Slovakia)

^e PONTIFICIA UNIVERSIDAD JAVERIANA   (Colombia)

^f Stress Relief and Memory Training Center   (United States)

Author keywords

31P NMR; Aging; Antioxidants; Brain; Mitochondria; OXPHOS

Indexed keywords

ADENOSINE TRIPHOSPHATE; ANTIOXIDANT;

AGING; ANIMAL; ARTICLE; BRAIN; ENERGY METABOLISM; MALE; METABOLISM; MITOCHONDRION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OXIDATION REDUCTION REACTION; OXIDATIVE PHOSPHORYLATION; PHYSIOLOGY; RAT; WISTAR RAT;

ADENOSINE TRIPHOSPHATE; AGING; ANIMALS; ANTIOXIDANTS; BRAIN; ENERGY METABOLISM; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MITOCHONDRIA; OXIDATION-REDUCTION; OXIDATIVE PHOSPHORYLATION; RATS; RATS, WISTAR;

ANIMALIA; RATTUS; RATTUS NORVEGICUS;

EID: 78649694761     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2009.00879.x     Document Type: Article

References (59)

1. Dogru-Abbasoglu S, Tamer-Toptani S, Ugurnal B, et al Lipid peroxidation and antioxidant enzymes in livers and brains of aged rats. Mech Ageing Dev. 1997; 98: 177-80.
2. Evans PH. Free radicals in brain metabolism and pathology. Br Med Bull. 1993; 49: 577-87.
3. Bowling AC, Mutisya EM, Walker LC, et al Age-dependent impairment of mitochondrial function in primate brain. J Neurochem. 1993; 60: 1964-7.
4. Fiskum G, Murphy AN, Beal MF. Mitochondria in neurodegeneration: acute ischemia and chronic neurodegenerative diseases. J Cereb Blood Flow Metab. 1999; 19: 351-69.
5. Chance B, Sies H, Boveris A. Hydroperoxide metabolism in mammalian organs. Physiol Rev. 1979; 59: 527-605.
6. Harman D. The biologic clock: the mitochondria J Am Geriatr Soc. 1972; 20: 145-7.
7. Kwong LK, Sohal RS. Substrate and site specificity of hydrogen peroxide generation in mouse mitochondria. Arch Biochem Biophys. 19981; 350: 118-26.
8. Miquel J, Economos AC, Fleming J, et al Mitochondrial role in cell aging. Exp Gerontol. 1980; 15: 575-91.
9. Linseman DA. Targeting oxidative stress for neuroprotection. Antioxidants Redox Signal. 2008; 11: 421-24.
10. Coyle JT, Puttfarcken P. Oxidative stress, glutamate, and neurodegenerative disorders. Science. 1993; 262: 689-95.
11. Aliev G, Obrenovich ME, Reddy VP, et al Antioxidant therapy in Alzheimer's disease: theory and practice. Mini Rev Med Chem. 2008; 8: 1395-406.
12. Beal MF. Mitochondrial dysfunction in neurodegenerative diseases. Biochim Biophys Acta. 1998; 1366: 211-23.
13. Matthews RT, Yang L, Jenkins BG, et al Neuroprotective effects of creatine and cyclocreatine in animal models of Huntington's disease. J Neurosci. 1998; 18: 156-63.
14. Corbett RJ, Laptook AR. Age-related changes in swine brain creatine kinase-catalyzed 31P exchange measured in vivo using 31P NMR magnetization transfer. J Cereb Blood Flow Metab. 1994; 14: 1070-7.
15. Sauter A, Rudin M. Determination of creatine kinase kinetic parameters in rat brain by NMR magnetization transfer. Correlation with brain function. J Biol Chem. 1993; 268: 13166-71.
16. Clark JF, Harris GI, Dillon PF. Multisite saturation transfer using DANTE and continuous wave. Magn Reson Med. 1991; 17: 274-8.
17. Forsen F, Hoffman R. Study of moderately rapid chemical exchange reactions by means of nuclear magnetic double resonance. J Chem Phys. 1963; 39: 2892-901.
18. Sarma JS, Ikeda S, Fischer R, et al Biochemical and contractile properties of heart muscle after prolonged alcohol administration. J Mol Cell Cardiol. 1976; 8: 951-72.
19. Lowry OH, Rosebrough NJ, Farr AL, et al Protein measurement with the Folin phenol reagent. J Biol Chem. 1951; 193: 265-75.
20. Aebi H. Catalase in vitro. Methods Enzymol. 1984; 105: 121-6.
21. Wendel A. Glutathione peroxidase. Methods Enzymol. 1981; 77: 325-33.
22. Benzie IF, Strain JJ. The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay. Anal Biochem. 1996; 239: 70-6.
23. Schosinsky KH, Lehmann HP, Beeler MF. Measurement of ceruloplasmin from its oxidase activity in serum by use of o-dianisidine dihydrochloride. Clin Chem. 1974; 20: 1556-63.
24. Aliev G, Gasimov E, Obrenovich ME, et al Atherosclerotic lesions and mitochondria DNA deletions in brain microvessels: implication in the pathogenesis of Alzheimer's disease. Vasc Health Risk Manag. 2008; 4: 721-30.
25. Aliev G, Palacios H, Walrafen B, et al. Brain mitochondria as a primary target in the development of treatment strategies for Alzheimer disease. Int J Biochim Cell Biol. 2009 (in press). doi:.
26. Kunz WS, Kuznetsov AV, Clark JF, et al Metabolic consequences of the cytochrome c oxidase deficiency in brain of copper-deficient Mo(vbr) mice. J Neurochem. 1999; 72: 1580-5.
27. Raz N, Rodrigue KM, Acker JD. Hypertension and the brain: vulnerability of the prefrontal regions and executive functions. Behav Neurosci. 2003; 117: 1169-80.
28. Acuna-Castroviejo D, Martin M, Macias M, et al Melatonin, mitochondria, and cellular bioenergetics. J Pineal Res. 2001; 30: 65-74.
29. Hirai K, Aliev G, Nunomura A, et al Mitochondrial abnormalities in Alzheimer's disease. J Neurosci. 2001; 21: 3017-23.
30. Aliev G, Smith MA, De La Torre JC, et al Mitochondria as a primary target for vascular hypoperfusion and oxidative stress in Alzheimer's disease. Mitochondrion. 2004; 4: 649-63.
31. Aliyev A, Chen SG, Seyidova D, et al Mitochondria DNA deletions in atherosclerotic hypoperfused brain microvessels as a primary target for the development of Alzheimer's disease. J Neurol Sci. 2005; 229-230: 285-92.
32. Schulz JB, Matthews RT, Klockgether T, et al The role of mitochondrial dysfunction and neuronal nitric oxide in animal models of neurodegenerative diseases. Mol Cell Biochem. 1997; 174: 193-7.
33. Rao AV, Balachandran B. Role of oxidative stress and antioxidants in neurodegenerative diseases. Nutritional neuroscience. 2002; 5: 291-309.
34. Castellani R, Hirai K, Aliev G, et al Role of mitochondrial dysfunction in Alzheimer's disease. J Neurosci Res. 2002; 70: 357-60.
35. Aliev G, Liu J, Shenk JC, et al Neuronal mitochondrial amelioration by feeding acetyl-L-carnitine and lipoic acid to aged rats. J Cell Mol Med. 2009; 13: 320-33.
36. Erecinska M, Silver IA. ATP and brain function. J Cereb Blood Flow Metab. 1989; 9: 2-19.
37. Attwell D, Laughlin SB. An energy budget for signaling in the grey matter of the brain. J Cereb Blood Flow Metab. 2001; 21: 1133-45.
38. Kemp GJ. Non-invasive methods for studying brain energy metabolism: what they show and what it means. Dev Neurosci. 2000; 22: 418-28.
39. Raichle ME, Mintun MA. Brain work and brain imaging. Annu Rev Neurosci. 2006; 29: 449-76.
40. Du F, Zhu XH, Qiao H, et al Efficient in vivo 31P magnetization transfer approach for noninvasively determining multiple kinetic parameters and metabolic fluxes of ATP metabolism in the human brain. Magn Reson Med. 2007; 57: 103-14.
41. Lei H, Ugurbil K, Chen W. Measurement of unidirectional Pi to ATP flux in human visual cortex at 7 T by using in vivo 31P magnetic resonance spectroscopy. Proc Natl Acad Sci USA. 2003; 100: 14409-14.
42. Degani H, Alger JR, Shulman RG, et al 31P magnetization transfer studies of creatine kinase kinetics in living rabbit brain. Magn Reson Med. 1987; 5: 1-12.
43. Ugurbil K. Magnetization transfer measurements of creatine kinase and ATPase rates in intact hearts. Circulation. 1985; 72: IV94-6.
44. Long J, Gao F, Tong L, et al Mitochondrial decay in the brains of old rats: ameliorating effect of alpha-lipoic acid and acetyl-L-carnitine. Neurochem Res. 2009; 34: 755-63.
45. Halliwell B. Reactive oxygen species and the central nervous system. J Neurochem. 1992; 59: 1609-23.
46. Halliwell B. Antioxidant defence mechanisms: from the beginning to the end (of the beginning). Free Radic Res. 1999; 31: 261-72.
47. Cassarino DS, Bennett JP Jr. An evaluation of the role of mitochondria in neurodegenerative diseases: mitochondrial mutations and oxidative pathology, protective nuclear responses, and cell death in neurodegeneration. Brain Res Brain Res Rev. 1999; 29: 1-25.
48. Otterbein LE, Choi AM. Heme oxygenase: colors of defense against cellular stress. Am J Physiol Lung Cell Mol Physiol. 2000; 279: L1029-37.
49. Akai F, Maeda M, Suzuki K, et al Immunocytochemical localization of manganese superoxide dismutase (Mn-SOD) in the hippocampus of the rat. Neurosci Lett. 1990; 115: 19-23.
50. Manganaro F, Chopra VS, Mydlarski MB, et al Redox perturbations in cysteamine-stressed astroglia: implications for inclusion formation and gliosis in the aging brain. Free Radic Biol Med. 1995; 19: 823-35.
51. Beckman KB, Ames BN. The free radical theory of aging matures. Physiol Rev. 1998; 78: 547-81.
52. Beckman KB, Ames BN. Mitochondrial aging: open questions. Ann N Y Acad Sci. 1998; 854: 118-27.
53. Beckman KB, Ames BN. Endogenous oxidative damage of mtDNA. Mutat Res. 1999; 424: 51-8.
54. Wallace DC. Mitochondrial diseases in man and mouse. Science. 1999; 283: 1482-8.
55. Serrano F, Klann E. Reactive oxygen species and synaptic plasticity in the aging hippocampus. Ageing Res Rev. 2004; 3: 431-43.
56. Sarti C, Pantoni L, Bartolini L, et al Cognitive impairment and chronic cerebral hypoperfusion: what can be learned from experimental models. J Neurol Sci. 2002; 203-204: 263-6.
57. De La Torre JC. Critically attained threshold of cerebral hypoperfusion: the CATCH hypothesis of Alzheimer's pathogenesis. Neurobiol Aging. 2000; 21: 331-42.
58. De La Torre JC. Alzheimer disease as a vascular disorder: nosological evidence. Stroke. 2002; 33: 1152-62.
59. Mueller SG, Schuff N, Weiner MW. Evaluation of treatment effects in Alzheimer's and other neurodegenerative diseases by MRI and MRS. NMR Biomed. 2006; 19: 655-68.